76 results
8-K
EX-10.2
VTVT
vTv Therapeutics Inc - Ordinary Shares
28 Feb 24
Proceeds to fully fund first Phase 3 study of cadisegliatin, expected to initiate in mid-2024
8:08am
8-K
EX-10.1
VTVT
vTv Therapeutics Inc - Ordinary Shares
28 Feb 24
Proceeds to fully fund first Phase 3 study of cadisegliatin, expected to initiate in mid-2024
8:08am
8-K
EX-10.3
VTVT
vTv Therapeutics Inc - Ordinary Shares
28 Feb 24
Proceeds to fully fund first Phase 3 study of cadisegliatin, expected to initiate in mid-2024
8:08am
8-K
EX-10.4
VTVT
vTv Therapeutics Inc - Ordinary Shares
28 Feb 24
Proceeds to fully fund first Phase 3 study of cadisegliatin, expected to initiate in mid-2024
8:08am
8-K
EX-10.5
o0v 6y4fvd
28 Feb 24
Proceeds to fully fund first Phase 3 study of cadisegliatin, expected to initiate in mid-2024
8:08am
8-K
EX-10.1
sn6tqsgkdvgxwy
13 Dec 22
Departure of Directors or Certain Officers
9:02am
8-K
EX-10.2
tt3vtq 6rn2yaw8
27 Jul 22
Departure of Directors or Certain Officers
7:26am
8-K
EX-10.1
1udo5f
27 Jul 22
Departure of Directors or Certain Officers
7:26am
8-K
EX-10.1
wi1k6k5
25 Jul 22
Entry into a Material Definitive Agreement
7:11am
8-K
EX-10.1
ahvv2
2 Dec 21
Departure of Directors or Certain Officers
5:17pm
8-K
EX-10.2
cu5bknm dsnhjhf6
20 Oct 21
Departure of Directors or Certain Officers
9:00am
8-K
EX-10.3
x43sxqnm0np 4ds05
20 Oct 21
Departure of Directors or Certain Officers
9:00am
8-K
EX-10.1
9vu rt2sprf
20 Oct 21
Departure of Directors or Certain Officers
9:00am